Connect Sign In
LabMind podcasts
|
May 9, 2024 |
Special 40th Anniversary Edition of ARUP’s Magnify Magazine Now Available Online This issue highlights milestones in ARUP’s history, gives a glimpse into the company’s future, and includes a special feature: a video of ARUP founders and current leaders reminiscing and celebrating. |
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. |
April 29, 2024 |
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs. |
Nicola Longo, MD, PhD, has spent more than 20 years at University of Utah Health and ARUP Laboratories treating patients in his clinic and working with wife Marzia Pasquali, PhD, FACMG, to advance the diagnosis of inherited metabolic disorders. |
April 26, 2024 | Nicola Longo, who with his wife, Marzia Pasquali, is credited with expanding screening for a treatable metabolic disorder, is leaving for UCLA while Pasquali stays at ARUP to continue key projects. |
The connectivity platform LKOrbit streamlines test ordering, reporting, and billing for laboratory outreach operations. |
April 24, 2024 |
ARUP Partners With ELLKAY to Bring Connectivity Solutions to Health System Outreach Operations A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations. |
Jan Wintch, CQA(ASQ), senior quality and regulatory affairs specialist, has worked at ARUP since the company was created in 1984. Forty years later, she said she is still learning new things every day. |
April 19, 2024 |
Four Decades Together: Senior Quality Specialist Celebrates Her Anniversary and ARUP’s Jan Wintch, CQA(ASQ), senior quality specialist, has worked at ARUP since the company’s inception. She enjoys her current role in Quality and remembers ARUP’s early years fondly. |
The American College of Medical Genetics and Genomics (ACMG) recommends whole exome and whole genome sequencing (WES/WGS) be considered as a first- or second-tier test for patients with congenital anomalies (CAs), developmental delay (DD), or intellectual disability (ID). |
April 18, 2024 |
ARUP Consult Updates Guidance on Testing for Autism Spectrum Disorder and Other Developmental Delays The ARUP Consult Laboratory Testing for Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder topic now includes exome and genome sequencing as a first- or second-tier test. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine We accelerate groundbreaking diagnostic and prognostic technologies to drive life-changing innovation. Our large, single-site operation and renowned quality framework, combined with our extensive expertise, provide an ideal incubator to advance custom projects for innovative partners. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat